Innovation, precision and reinvention at EuroPCR 2024
Are you ready for EuroPCR 2024?
days
hours
minutes
seconds
Join Edwards Lifesciences at this year’s EuroPCR in Paris
Join Edwards Lifesciences at EuroPCR 2024 and learn about our growing portfolio for treating your patients. We would love to welcome you to our TNT sessions, where you will be able to engage with our international panel of experts and learn more about the latest innovations in the field of transcatheter therapies featuring the SAPIEN 3 Ultra Resilia, EVOQUE and PASCAL Precision systems.
We are thrilled to share that we have had the opportunity to contribute to the ‘Training Village’ activities of GE Healthcare and Siemens. This unique program offers an in-depth understanding of various products, therapies, techniques and technologies. We encourage you to take advantage of this exceptional opportunity to broaden your knowledge and stay at the forefront of your field.
Hear about the 3 reasons to meet at EuroPCR by Neal Uren and Fabienne Durat
Vice President Medical Affairs and Senior Marketing Director for Transcatheter Mitral and Tricuspid Therapies business unit.
TNT Session
Anchorperson: B. Prendergast
Spokespersons: J. Hausleiter, M. Joner
17:00 - 18:30
Théâtre Bleu
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE systems
Session title
Speaker
RESILIA tissue - Why does it have the potential to improve the LTM of all patients
Kentaro Hayashida
Keio University School of Medicine, Tokyo, Japan
Rahul Sharma
Stanford Healthcare, Stanford, United States
Patient presentation
Michael Joner
German Heart Center, Munich, Germany
Live case procedure with the SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
Luis Nombela-Franco
Hospital Universitario Vithas Madrid La Milagrosa, Madrid, Spain
Pilar Jiménez-Quevedo
Hospital Universitario Vithas Madrid La Milagrosa, Madrid, Spain
Patient presentation
Jörg Hausleiter
Ludwig-Maximilians University, Munich, Germany
Imaging analysis
Maria Isabel Körber
University of Cologne, Germany
Live case with the EVOQUE Transcatheter Tricuspid Valve Replacement System
Philipp Lurz
University Medical Center of Mainz, Germany
Contribution to Training Villages
Visit our Training Villages in partnership with GE Healthcare and Siemens.
To receive a summary of our EuroPCR 2024 activities, recordings, slide decks and future developments, join the Edwards Lifesciences community today.
MR = Mitral Regurgitation; DMR = Degenerative Mitral Regurgitation; TEER = Transcatheter Edge-to-Edge Repair, LTM = Lifetime Management; TR = Tricuspid Regurgitation; TTVR = Transcatheter Tricuspid Valve Replacement ; TNT = Tools and Techniques.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
No clinical data are available to evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.